Nicholson RI - Search Results

1

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.

Hutcheson IR, Goddard L, Barrow D, McClelland RA, Francies HE, Knowlden JM, Nicholson RI, Gee JM. Hutcheson IR, et al. Among authors: nicholson ri. Breast Cancer Res. 2011 Mar 11;13(2):R29. doi: 10.1186/bcr2848. Breast Cancer Res. 2011. PMID: 21396094 Free PMC article.

2

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization.

Gee JM, Nicholson RI. Gee JM, et al. Among authors: nicholson ri. Breast Cancer Res. 2003;5(3):126-9. doi: 10.1186/bcr584. Epub 2003 Feb 20. Breast Cancer Res. 2003. PMID: 12793892 Free PMC article. Review.

3

Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.

Hutcheson IR, Knowlden JM, Madden TA, Barrow D, Gee JM, Wakeling AE, Nicholson RI. Hutcheson IR, et al. Among authors: nicholson ri. Breast Cancer Res Treat. 2003 Sep;81(1):81-93. doi: 10.1023/A:1025484908380. Breast Cancer Res Treat. 2003. PMID: 14531500

4

The biology of antihormone failure in breast cancer.

Nicholson RI, Gee JM, Knowlden J, McClelland R, Madden TA, Barrow D, Hutcheson I. Nicholson RI, et al. Breast Cancer Res Treat. 2003;80 Suppl 1:S29-34; discussion S35. doi: 10.1023/a:1025467500433. Breast Cancer Res Treat. 2003. PMID: 14535532 Review.

5

Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer.

Rushmere NK, Knowlden JM, Gee JM, Harper ME, Robertson JF, Morgan BP, Nicholson RI. Rushmere NK, et al. Among authors: nicholson ri. Int J Cancer. 2004 Mar 1;108(6):930-6. doi: 10.1002/ijc.11606. Int J Cancer. 2004. PMID: 14712499

6

Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer.

Gee JM, Giles MG, Nicholson RI. Gee JM, et al. Among authors: nicholson ri. Breast Cancer Res. 2004;6(4):162-3. doi: 10.1186/bcr904. Epub 2004 Jun 9. Breast Cancer Res. 2004. PMID: 15217488 Free PMC article. No abstract available.

7

Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells.

Jordan NJ, Gee JM, Barrow D, Wakeling AE, Nicholson RI. Jordan NJ, et al. Among authors: nicholson ri. Breast Cancer Res Treat. 2004 Sep;87(2):167-80. doi: 10.1023/B:BREA.0000041623.21338.47. Breast Cancer Res Treat. 2004. PMID: 15377841

8

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.

Hiscox S, Morgan L, Green TP, Barrow D, Gee J, Nicholson RI. Hiscox S, et al. Among authors: nicholson ri. Breast Cancer Res Treat. 2006 Jun;97(3):263-74. doi: 10.1007/s10549-005-9120-9. Epub 2005 Dec 7. Breast Cancer Res Treat. 2006. PMID: 16333527

9

Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy.

Hutcheson IR, Knowlden JM, Jones HE, Burmi RS, McClelland RA, Barrow D, Gee JM, Nicholson RI. Hutcheson IR, et al. Among authors: nicholson ri. Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S89-97. doi: 10.1677/erc.1.01279. Endocr Relat Cancer. 2006. PMID: 17259562 Review.

10

Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

Hutcheson IR, Knowlden JM, Hiscox SE, Barrow D, Gee JM, Robertson JF, Ellis IO, Nicholson RI. Hutcheson IR, et al. Among authors: nicholson ri. Breast Cancer Res. 2007;9(4):R50. doi: 10.1186/bcr1754. Breast Cancer Res. 2007. PMID: 17686159 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters